nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—Laryngospasm—Etoposide—testicular cancer	0.0224	0.0224	CcSEcCtD
Sufentanil—Urinary incontinence—Ifosfamide—testicular cancer	0.0204	0.0204	CcSEcCtD
Sufentanil—Apnoea—Etoposide—testicular cancer	0.0197	0.0197	CcSEcCtD
Sufentanil—Body temperature increased—Carboplatin—testicular cancer	0.0175	0.0175	CcSEcCtD
Sufentanil—Bronchospasm—Bleomycin—testicular cancer	0.0153	0.0153	CcSEcCtD
Sufentanil—Cardiac arrest—Ifosfamide—testicular cancer	0.0146	0.0146	CcSEcCtD
Sufentanil—Urinary retention—Ifosfamide—testicular cancer	0.0146	0.0146	CcSEcCtD
Sufentanil—Bronchospasm—Ifosfamide—testicular cancer	0.0131	0.0131	CcSEcCtD
Sufentanil—Apnoea—Methotrexate—testicular cancer	0.0118	0.0118	CcSEcCtD
Sufentanil—Cardiac arrest—Etoposide—testicular cancer	0.0115	0.0115	CcSEcCtD
Sufentanil—Confusional state—Chlorambucil—testicular cancer	0.0115	0.0115	CcSEcCtD
Sufentanil—Injection site pain—Epirubicin—testicular cancer	0.0115	0.0115	CcSEcCtD
Sufentanil—Chills—Bleomycin—testicular cancer	0.0112	0.0112	CcSEcCtD
Sufentanil—Hypertension—Vinblastine—testicular cancer	0.0111	0.0111	CcSEcCtD
Sufentanil—Erythema—Bleomycin—testicular cancer	0.0108	0.0108	CcSEcCtD
Sufentanil—Bradycardia—Ifosfamide—testicular cancer	0.0108	0.0108	CcSEcCtD
Sufentanil—Injection site pain—Doxorubicin—testicular cancer	0.0106	0.0106	CcSEcCtD
Sufentanil—Urinary tract disorder—Ifosfamide—testicular cancer	0.0105	0.0105	CcSEcCtD
Sufentanil—Urethral disorder—Ifosfamide—testicular cancer	0.0104	0.0104	CcSEcCtD
Sufentanil—Chills—Dactinomycin—testicular cancer	0.0104	0.0104	CcSEcCtD
Sufentanil—Bronchospasm—Etoposide—testicular cancer	0.0103	0.0103	CcSEcCtD
Sufentanil—Erythema—Dactinomycin—testicular cancer	0.0101	0.0101	CcSEcCtD
Sufentanil—Chills—Ifosfamide—testicular cancer	0.00954	0.00954	CcSEcCtD
Sufentanil—Arrhythmia—Ifosfamide—testicular cancer	0.0095	0.0095	CcSEcCtD
Sufentanil—Feeling abnormal—Chlorambucil—testicular cancer	0.00941	0.00941	CcSEcCtD
Sufentanil—Bradycardia—Cisplatin—testicular cancer	0.00933	0.00933	CcSEcCtD
Sufentanil—Erythema—Ifosfamide—testicular cancer	0.00925	0.00925	CcSEcCtD
Sufentanil—Urinary tract disorder—Cisplatin—testicular cancer	0.00905	0.00905	CcSEcCtD
Sufentanil—Body temperature increased—Chlorambucil—testicular cancer	0.00903	0.00903	CcSEcCtD
Sufentanil—Urethral disorder—Cisplatin—testicular cancer	0.00898	0.00898	CcSEcCtD
Sufentanil—Confusional state—Bleomycin—testicular cancer	0.00891	0.00891	CcSEcCtD
Sufentanil—Anaphylactic shock—Bleomycin—testicular cancer	0.00884	0.00884	CcSEcCtD
Sufentanil—Feeling abnormal—Vinblastine—testicular cancer	0.00862	0.00862	CcSEcCtD
Sufentanil—Hypersensitivity—Chlorambucil—testicular cancer	0.00841	0.00841	CcSEcCtD
Sufentanil—Urinary tract disorder—Etoposide—testicular cancer	0.00829	0.00829	CcSEcCtD
Sufentanil—Hypotension—Bleomycin—testicular cancer	0.00826	0.00826	CcSEcCtD
Sufentanil—Urethral disorder—Etoposide—testicular cancer	0.00823	0.00823	CcSEcCtD
Sufentanil—Arrhythmia—Cisplatin—testicular cancer	0.00819	0.00819	CcSEcCtD
Sufentanil—Pruritus—Chlorambucil—testicular cancer	0.00808	0.00808	CcSEcCtD
Sufentanil—Hypertension—Ifosfamide—testicular cancer	0.00799	0.00799	CcSEcCtD
Sufentanil—Erythema—Cisplatin—testicular cancer	0.00798	0.00798	CcSEcCtD
Sufentanil—Hypersensitivity—Vinblastine—testicular cancer	0.00771	0.00771	CcSEcCtD
Sufentanil—Confusional state—Ifosfamide—testicular cancer	0.00762	0.00762	CcSEcCtD
Sufentanil—Anaphylactic shock—Ifosfamide—testicular cancer	0.00755	0.00755	CcSEcCtD
Sufentanil—Chills—Etoposide—testicular cancer	0.00753	0.00753	CcSEcCtD
Sufentanil—Feeling abnormal—Bleomycin—testicular cancer	0.00728	0.00728	CcSEcCtD
Sufentanil—Vomiting—Chlorambucil—testicular cancer	0.00726	0.00726	CcSEcCtD
Sufentanil—Hypotension—Ifosfamide—testicular cancer	0.00706	0.00706	CcSEcCtD
Sufentanil—Body temperature increased—Bleomycin—testicular cancer	0.00699	0.00699	CcSEcCtD
Sufentanil—Dizziness—Vinblastine—testicular cancer	0.00692	0.00692	CcSEcCtD
Sufentanil—Feeling abnormal—Dactinomycin—testicular cancer	0.00679	0.00679	CcSEcCtD
Sufentanil—Nausea—Chlorambucil—testicular cancer	0.00678	0.00678	CcSEcCtD
Sufentanil—Somnolence—Ifosfamide—testicular cancer	0.00671	0.00671	CcSEcCtD
Sufentanil—Vomiting—Vinblastine—testicular cancer	0.00665	0.00665	CcSEcCtD
Sufentanil—Headache—Vinblastine—testicular cancer	0.00656	0.00656	CcSEcCtD
Sufentanil—Body temperature increased—Dactinomycin—testicular cancer	0.00652	0.00652	CcSEcCtD
Sufentanil—Anaphylactic shock—Cisplatin—testicular cancer	0.00651	0.00651	CcSEcCtD
Sufentanil—Hypersensitivity—Bleomycin—testicular cancer	0.00651	0.00651	CcSEcCtD
Sufentanil—Cardiac arrest—Epirubicin—testicular cancer	0.00647	0.00647	CcSEcCtD
Sufentanil—Tachycardia—Cisplatin—testicular cancer	0.00636	0.00636	CcSEcCtD
Sufentanil—Hypertension—Etoposide—testicular cancer	0.00631	0.00631	CcSEcCtD
Sufentanil—Pruritus—Bleomycin—testicular cancer	0.00625	0.00625	CcSEcCtD
Sufentanil—Feeling abnormal—Ifosfamide—testicular cancer	0.00622	0.00622	CcSEcCtD
Sufentanil—Nausea—Vinblastine—testicular cancer	0.00622	0.00622	CcSEcCtD
Sufentanil—Hypotension—Cisplatin—testicular cancer	0.00608	0.00608	CcSEcCtD
Sufentanil—Hypersensitivity—Dactinomycin—testicular cancer	0.00607	0.00607	CcSEcCtD
Sufentanil—Confusional state—Etoposide—testicular cancer	0.00601	0.00601	CcSEcCtD
Sufentanil—Cardiac arrest—Doxorubicin—testicular cancer	0.00599	0.00599	CcSEcCtD
Sufentanil—Body temperature increased—Ifosfamide—testicular cancer	0.00597	0.00597	CcSEcCtD
Sufentanil—Anaphylactic shock—Etoposide—testicular cancer	0.00597	0.00597	CcSEcCtD
Sufentanil—Tachycardia—Etoposide—testicular cancer	0.00582	0.00582	CcSEcCtD
Sufentanil—Vomiting—Bleomycin—testicular cancer	0.00562	0.00562	CcSEcCtD
Sufentanil—Hypotension—Etoposide—testicular cancer	0.00557	0.00557	CcSEcCtD
Sufentanil—Rash—Bleomycin—testicular cancer	0.00557	0.00557	CcSEcCtD
Sufentanil—Dermatitis—Bleomycin—testicular cancer	0.00557	0.00557	CcSEcCtD
Sufentanil—Hypersensitivity—Ifosfamide—testicular cancer	0.00556	0.00556	CcSEcCtD
Sufentanil—Feeling abnormal—Cisplatin—testicular cancer	0.00537	0.00537	CcSEcCtD
Sufentanil—Pruritus—Ifosfamide—testicular cancer	0.00534	0.00534	CcSEcCtD
Sufentanil—Somnolence—Etoposide—testicular cancer	0.0053	0.0053	CcSEcCtD
Sufentanil—Nausea—Bleomycin—testicular cancer	0.00525	0.00525	CcSEcCtD
Sufentanil—Vomiting—Dactinomycin—testicular cancer	0.00524	0.00524	CcSEcCtD
Sufentanil—Rash—Dactinomycin—testicular cancer	0.0052	0.0052	CcSEcCtD
Sufentanil—Body temperature increased—Cisplatin—testicular cancer	0.00515	0.00515	CcSEcCtD
Sufentanil—Dizziness—Ifosfamide—testicular cancer	0.00499	0.00499	CcSEcCtD
Sufentanil—Urinary tract disorder—Methotrexate—testicular cancer	0.00497	0.00497	CcSEcCtD
Sufentanil—Urethral disorder—Methotrexate—testicular cancer	0.00493	0.00493	CcSEcCtD
Sufentanil—Feeling abnormal—Etoposide—testicular cancer	0.00492	0.00492	CcSEcCtD
Sufentanil—Nausea—Dactinomycin—testicular cancer	0.0049	0.0049	CcSEcCtD
Sufentanil—Vomiting—Ifosfamide—testicular cancer	0.0048	0.0048	CcSEcCtD
Sufentanil—Hypersensitivity—Cisplatin—testicular cancer	0.0048	0.0048	CcSEcCtD
Sufentanil—Bradycardia—Epirubicin—testicular cancer	0.00479	0.00479	CcSEcCtD
Sufentanil—Rash—Ifosfamide—testicular cancer	0.00476	0.00476	CcSEcCtD
Sufentanil—Dermatitis—Ifosfamide—testicular cancer	0.00476	0.00476	CcSEcCtD
Sufentanil—Body temperature increased—Etoposide—testicular cancer	0.00472	0.00472	CcSEcCtD
Sufentanil—Urinary tract disorder—Epirubicin—testicular cancer	0.00465	0.00465	CcSEcCtD
Sufentanil—Urethral disorder—Epirubicin—testicular cancer	0.00461	0.00461	CcSEcCtD
Sufentanil—Chills—Methotrexate—testicular cancer	0.00451	0.00451	CcSEcCtD
Sufentanil—Nausea—Ifosfamide—testicular cancer	0.00449	0.00449	CcSEcCtD
Sufentanil—Bradycardia—Doxorubicin—testicular cancer	0.00443	0.00443	CcSEcCtD
Sufentanil—Hypersensitivity—Etoposide—testicular cancer	0.0044	0.0044	CcSEcCtD
Sufentanil—Erythema—Methotrexate—testicular cancer	0.00438	0.00438	CcSEcCtD
Sufentanil—Urinary tract disorder—Doxorubicin—testicular cancer	0.0043	0.0043	CcSEcCtD
Sufentanil—Urethral disorder—Doxorubicin—testicular cancer	0.00427	0.00427	CcSEcCtD
Sufentanil—Chills—Epirubicin—testicular cancer	0.00422	0.00422	CcSEcCtD
Sufentanil—Pruritus—Etoposide—testicular cancer	0.00422	0.00422	CcSEcCtD
Sufentanil—Arrhythmia—Epirubicin—testicular cancer	0.0042	0.0042	CcSEcCtD
Sufentanil—Vomiting—Cisplatin—testicular cancer	0.00414	0.00414	CcSEcCtD
Sufentanil—Rash—Cisplatin—testicular cancer	0.00411	0.00411	CcSEcCtD
Sufentanil—Dermatitis—Cisplatin—testicular cancer	0.0041	0.0041	CcSEcCtD
Sufentanil—Erythema—Epirubicin—testicular cancer	0.0041	0.0041	CcSEcCtD
Sufentanil—Dizziness—Etoposide—testicular cancer	0.00394	0.00394	CcSEcCtD
Sufentanil—Chills—Doxorubicin—testicular cancer	0.00391	0.00391	CcSEcCtD
Sufentanil—Arrhythmia—Doxorubicin—testicular cancer	0.00389	0.00389	CcSEcCtD
Sufentanil—Nausea—Cisplatin—testicular cancer	0.00387	0.00387	CcSEcCtD
Sufentanil—Vomiting—Etoposide—testicular cancer	0.00379	0.00379	CcSEcCtD
Sufentanil—Erythema—Doxorubicin—testicular cancer	0.00379	0.00379	CcSEcCtD
Sufentanil—Rash—Etoposide—testicular cancer	0.00376	0.00376	CcSEcCtD
Sufentanil—Dermatitis—Etoposide—testicular cancer	0.00376	0.00376	CcSEcCtD
Sufentanil—Headache—Etoposide—testicular cancer	0.00374	0.00374	CcSEcCtD
Sufentanil—Confusional state—Methotrexate—testicular cancer	0.0036	0.0036	CcSEcCtD
Sufentanil—Anaphylactic shock—Methotrexate—testicular cancer	0.00357	0.00357	CcSEcCtD
Sufentanil—Nausea—Etoposide—testicular cancer	0.00354	0.00354	CcSEcCtD
Sufentanil—Hypertension—Epirubicin—testicular cancer	0.00354	0.00354	CcSEcCtD
Sufentanil—Confusional state—Epirubicin—testicular cancer	0.00337	0.00337	CcSEcCtD
Sufentanil—Anaphylactic shock—Epirubicin—testicular cancer	0.00334	0.00334	CcSEcCtD
Sufentanil—Hypotension—Methotrexate—testicular cancer	0.00334	0.00334	CcSEcCtD
Sufentanil—Hypertension—Doxorubicin—testicular cancer	0.00327	0.00327	CcSEcCtD
Sufentanil—Tachycardia—Epirubicin—testicular cancer	0.00326	0.00326	CcSEcCtD
Sufentanil—Somnolence—Methotrexate—testicular cancer	0.00318	0.00318	CcSEcCtD
Sufentanil—Hypotension—Epirubicin—testicular cancer	0.00312	0.00312	CcSEcCtD
Sufentanil—Confusional state—Doxorubicin—testicular cancer	0.00312	0.00312	CcSEcCtD
Sufentanil—Anaphylactic shock—Doxorubicin—testicular cancer	0.00309	0.00309	CcSEcCtD
Sufentanil—Tachycardia—Doxorubicin—testicular cancer	0.00302	0.00302	CcSEcCtD
Sufentanil—Somnolence—Epirubicin—testicular cancer	0.00297	0.00297	CcSEcCtD
Sufentanil—Feeling abnormal—Methotrexate—testicular cancer	0.00294	0.00294	CcSEcCtD
Sufentanil—Hypotension—Doxorubicin—testicular cancer	0.00289	0.00289	CcSEcCtD
Sufentanil—Body temperature increased—Methotrexate—testicular cancer	0.00282	0.00282	CcSEcCtD
Sufentanil—Feeling abnormal—Epirubicin—testicular cancer	0.00276	0.00276	CcSEcCtD
Sufentanil—Somnolence—Doxorubicin—testicular cancer	0.00275	0.00275	CcSEcCtD
Sufentanil—Body temperature increased—Epirubicin—testicular cancer	0.00264	0.00264	CcSEcCtD
Sufentanil—Hypersensitivity—Methotrexate—testicular cancer	0.00263	0.00263	CcSEcCtD
Sufentanil—Feeling abnormal—Doxorubicin—testicular cancer	0.00255	0.00255	CcSEcCtD
Sufentanil—Pruritus—Methotrexate—testicular cancer	0.00253	0.00253	CcSEcCtD
Sufentanil—Hypersensitivity—Epirubicin—testicular cancer	0.00246	0.00246	CcSEcCtD
Sufentanil—Body temperature increased—Doxorubicin—testicular cancer	0.00245	0.00245	CcSEcCtD
Sufentanil—Pruritus—Epirubicin—testicular cancer	0.00237	0.00237	CcSEcCtD
Sufentanil—Dizziness—Methotrexate—testicular cancer	0.00236	0.00236	CcSEcCtD
Sufentanil—Hypersensitivity—Doxorubicin—testicular cancer	0.00228	0.00228	CcSEcCtD
Sufentanil—Vomiting—Methotrexate—testicular cancer	0.00227	0.00227	CcSEcCtD
Sufentanil—Rash—Methotrexate—testicular cancer	0.00225	0.00225	CcSEcCtD
Sufentanil—Dermatitis—Methotrexate—testicular cancer	0.00225	0.00225	CcSEcCtD
Sufentanil—Headache—Methotrexate—testicular cancer	0.00224	0.00224	CcSEcCtD
Sufentanil—Dizziness—Epirubicin—testicular cancer	0.00221	0.00221	CcSEcCtD
Sufentanil—Pruritus—Doxorubicin—testicular cancer	0.00219	0.00219	CcSEcCtD
Sufentanil—Vomiting—Epirubicin—testicular cancer	0.00213	0.00213	CcSEcCtD
Sufentanil—Nausea—Methotrexate—testicular cancer	0.00212	0.00212	CcSEcCtD
Sufentanil—Rash—Epirubicin—testicular cancer	0.00211	0.00211	CcSEcCtD
Sufentanil—Dermatitis—Epirubicin—testicular cancer	0.00211	0.00211	CcSEcCtD
Sufentanil—Headache—Epirubicin—testicular cancer	0.00209	0.00209	CcSEcCtD
Sufentanil—Dizziness—Doxorubicin—testicular cancer	0.00205	0.00205	CcSEcCtD
Sufentanil—Nausea—Epirubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Sufentanil—Vomiting—Doxorubicin—testicular cancer	0.00197	0.00197	CcSEcCtD
Sufentanil—Rash—Doxorubicin—testicular cancer	0.00195	0.00195	CcSEcCtD
Sufentanil—Dermatitis—Doxorubicin—testicular cancer	0.00195	0.00195	CcSEcCtD
Sufentanil—Headache—Doxorubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Sufentanil—Nausea—Doxorubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
